Advertisement
U.S. markets open in 5 hours 15 minutes
  • S&P Futures

    5,209.50
    -5.25 (-0.10%)
     
  • Dow Futures

    39,223.00
    0.00 (0.00%)
     
  • Nasdaq Futures

    18,189.50
    -42.00 (-0.23%)
     
  • Russell 2000 Futures

    2,047.50
    -2.30 (-0.11%)
     
  • Crude Oil

    82.50
    -0.22 (-0.27%)
     
  • Gold

    2,158.20
    -6.10 (-0.28%)
     
  • Silver

    25.16
    -0.11 (-0.44%)
     
  • EUR/USD

    1.0853
    -0.0024 (-0.22%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.51
    +0.18 (+1.26%)
     
  • GBP/USD

    1.2695
    -0.0033 (-0.26%)
     
  • USD/JPY

    150.3660
    +1.2680 (+0.85%)
     
  • Bitcoin USD

    64,425.25
    -3,536.48 (-5.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,718.84
    -3.71 (-0.05%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Ackman apologizes for Valeant losses, calls bet a mistake

William Ackman speaks during the Sohn Investment Conference in New York May 4, 2015. REUTERS/Brendan McDermid

BOSTON (Reuters) - Billionaire investor William Ackman told investors that betting on Valeant Pharmaceuticals International Inc (VRX.TO) was a "huge mistake" and apologized "deeply and profoundly" for losing so much of his shareholders' money on the investment.

The bet on Valeant left Ackman's hedge fund Pershing Square Capital Management with back-to-back double-digit losses in 2015 and 2016 and tarnished his reputation as one of the hedge fund industry's most talented investors.

Ackman decided to sell his entire position earlier this month, suffering a roughly $4 billion loss since having bought the stake in early 2015.

"My approach to mistakes is that I personally assume 100 percent of the responsibility on behalf of the firm," he wrote in the firm's annual letter released on Tuesday evening.

The 50-year-old manager acknowledged the toll that it has taken on his image and said that he misjudged the management team in place when he bought the stock.

(Reporting by Svea Herbst-Bayliss; Editing by Lisa Shumaker)

Advertisement